| Having trouble viewing this email? View it as a Web page. You are subscribed to NCHHSTP Newsroom from the Centers for Disease Control and Prevention (CDC). Two new antibiotic regimens using existing drugs – injectable gentamicin in combination with oral azithromycin and oral gemifloxacin in combination with oral azithromycin –successfully treated gonorrhea infections in a clinical trial. The trial was conducted by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) to identify new treatment options in the face of growing antibiotic resistance. The findings will be presented this week by CDC’s Robert Kirkcaldy, M.D., at the 20th Meeting of The International Society for Sexually Transmitted Diseases Research (ISSTDR) in Vienna, Austria. Dr. Kirkcaldy served as the clinical trial’s principal investigator. Gonorrhea is one of the most common sexually transmitted diseases in the United States where more than 800,000 gonorrhea infections are estimated to occur each year. It remains critical for individuals to take steps to protect themselves from gonorrhea infection. The surest way to prevent infection is not having sex. For those who are sexually active, consistent and correct condom use and limiting the number of sex partners can help reduce the risk of infection. For more information, please see our press release or fact sheets on gonorrhea and antibiotic treatment of gonorrhea. |
Monday, 15 July 2013
NCHHSTP Newsroom: New Gonorrhea Treatment Regimens Successfully Treated Infections in CDC/NIH Clinical Trial
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment